Physician profile
Patrick M Quinn
NPI 1992817910
$3,470.90
in general payments reported to CMS, 2019-2025
23 companies · $201 in 2025
The $201 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $760 · 2020: $366 · 2021: $442 · 2022: $524 · 2023: $299 · 2024: $879 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,379.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impulse Dynamics (USA) INC. | $770.76 | 2021-2024 | Optimizer |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $386.74 | 2019-2025 | Lifevest |
| Smith+Nephew, INC. | $382.94 | 2019 | |
| Novartis Pharmaceuticals Corporation | $374.79 | 2019-2024 | |
| Boston Scientific Corporation | $254.44 | 2020-2025 | Rotapro, General - Therapies, Accolade Sr |
| Cardiovascular Systems INC. | $221.17 | 2020-2021 | |
| Edwards Lifesciences Corporation | $210.52 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Janssen Pharmaceuticals, INC | $193.04 | 2019-2024 | Xarelto |
| Medtronic, INC. | $162.61 | 2021-2025 | Micra, Hawkone |
| Astrazeneca Pharmaceuticals Lp | $67.53 | 2019-2021 | |
| Bardy Diagnostics, INC. | $60.00 | 2022 | |
| Abiomed | $54.77 | 2021-2023 | Impella |
| Regeneron Healthcare Solutions, INC. | $54.02 | 2019 | |
| Medtronic Vascular, INC. | $51.87 | 2019 | |
| Pfizer INC. | $42.90 | 2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $36.35 | 2020 | |
| Kestra Medical Technology Services, INC. | $27.81 | 2024 | Assure Wcd |
| Amgen INC. | $26.28 | 2020-2021 | |
| Biosense Webster, INC. | $20.71 | 2020 | |
| Sanofi-Aventis U.S. LLC | $20.17 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $19.25 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.25 | 2019 | |
| Allergan, INC. | $14.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Quinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.